Approval · Notice of Compliance 3226 · 1998
PRELAY: Notice of Compliance 3226
Issued September 30, 1998
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 3226
- Date
- September 30, 1998
- Company
- Sankyo U.S.A. CorporationNew York, New York, United States
- Product type
- Prescription Pharmaceutical
- Submission
- Supplement to a New Drug Submission (SNDS), supplement
- Submission class
- Admin
- Reason
- New strength 300mg, new indication: concomitant use with sulfonylure as in patients with type 2 diabetes
- Therapeutic class
- Antidiabetic agent, insulin reducing agent
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| PRELAY | 02238698 | — |
| PRELAY | Not yet assigned | — |
Medicinal ingredients
- TROGLITAZONE 300 MG per TAB
- TROGLITAZONE 200 MG per TAB
- TROGLITAZONE 400 MG per TAB